BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 8394479)

  • 1. Macromolecules that are colocalized with deposits of beta 2-microglobulin in hemodialysis-associated amyloidosis.
    Aruga E; Ozasa H; Teraoka S; Ota K
    Lab Invest; 1993 Aug; 69(2):223-30. PubMed ID: 8394479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Amyloidosis associated with long-term dialysis].
    Gejyo F; Maruyama H; Arakawa M
    Nihon Jinzo Gakkai Shi; 1995 Jan; 37(1):1-6. PubMed ID: 7699947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha 2-macroglobulin protects some of the protein constituents of dialysis-associated amyloidosis from protease degradation.
    Gouin-Charnet A; Mourad G; Argilés A
    Biochem Biophys Res Commun; 1997 Feb; 231(1):48-51. PubMed ID: 9070217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycosaminoglycans enhance the fibrillation propensity of the β2-microglobulin cleavage variant--ΔK58-β2m.
    Corlin DB; Johnsen CK; Nissen MH; Heegaard NH
    Biochem Biophys Res Commun; 2010 Nov; 402(2):247-51. PubMed ID: 20939999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of splenic glycosaminoglycans accumulated in vivo in experimentally induced amyloid-susceptible and amyloid-resistant mice.
    Sugumaran G; Elliott-Bryant R; Phung N; Vitseva O; Kuberan B; Lech M
    Scand J Immunol; 2004 Dec; 60(6):574-83. PubMed ID: 15584968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Amyloid deposits in hemodialysis patients: immunochemical analysis].
    Argiles A; Mourad G; Axelrud-Cavadore C; Cavadore JC; Mion C
    Nephrologie; 1987; 8(2):51-4. PubMed ID: 3302740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histochemical and immunohistochemical characterization of amyloid associated with chronic hemodialysis as beta 2-microglobulin.
    Shirahama T; Skinner M; Cohen AS; Gejyo F; Arakawa M; Suzuki M; Hirasawa Y
    Lab Invest; 1985 Dec; 53(6):705-9. PubMed ID: 2415776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. beta 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis.
    Miyata T; Oda O; Inagi R; Iida Y; Araki N; Yamada N; Horiuchi S; Taniguchi N; Maeda K; Kinoshita T
    J Clin Invest; 1993 Sep; 92(3):1243-52. PubMed ID: 8376584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A histological study on the synovial tissue of rat knee joints in the experimental beta 2-microglobulin derived amyloidosis].
    Ueda T
    Ryumachi; 1992 Aug; 32(4):308-17. PubMed ID: 1411793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous and lingual papules as a sign of beta 2 microglobulin-derived amyloidosis in a long-term hemodialysis patient.
    Uenotsuchi T; Imafuku S; Nagata M; Kiryu H; Morita K; Koga T; Furue M
    Eur J Dermatol; 2003; 13(4):393-5. PubMed ID: 12948922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Affinity binding of glycosaminoglycans with beta(2)-microglobulin.
    Ohashi K; Kisilevsky R; Yanagishita M
    Nephron; 2002 Feb; 90(2):158-68. PubMed ID: 11818700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue distribution of dialysis amyloidosis.
    Noël LH; Zingraff J; Bardin T; Atienza C; Kuntz D; Drüeke T
    Clin Nephrol; 1987 Apr; 27(4):175-8. PubMed ID: 3555909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphological and immunohistochemical findings in dialysis-related amyloidosis. An analysis of 16 cases.
    Solé M; Cardesa A; Palacín A; Muñoz-Gómez J; Campistol JM
    Appl Pathol; 1989; 7(6):350-60. PubMed ID: 2701266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current clinical aspects of dialysis-related amyloidosis in chronic dialysis patients.
    Saito A; Gejyo F
    Ther Apher Dial; 2006 Aug; 10(4):316-20. PubMed ID: 16911183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathological aspects of beta(2)-microglobulin amyloidosis.
    Jadoul M; Garbar C; van Ypersele de Strihou C
    Semin Dial; 2001; 14(2):86-9. PubMed ID: 11264772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic distribution of beta 2-microglobulin-derived amyloidosis in patients who undergo long-term hemodialysis. Report of seven cases and review of the literature.
    Gal R; Korzets A; Schwartz A; Rath-Wolfson L; Gafter U
    Arch Pathol Lab Med; 1994 Jul; 118(7):718-21. PubMed ID: 8024407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta 2-microglobulin amyloidosis: a sternoclavicular joint biopsy study in hemodialysis patients.
    Zingraff J; Noël LH; Bardin T; Kuntz D; Dubost C; Drüeke T
    Clin Nephrol; 1990 Feb; 33(2):94-7. PubMed ID: 2178825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein E and alpha 1-antichymotrypsin in dialysis-related amyloidosis.
    Gejyo F; Kimura H; Suzuki S; Miyazaki R; Naiki H; Nakakuki K
    Kidney Int Suppl; 1997 Nov; 62():S75-8. PubMed ID: 9350687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of conformational change in the C-terminus of beta2-microglobulin in dialysis-related amyloidosis.
    Kim J; Motomiya Y; Ueda M; Nakamura M; Misumi Y; Saito S; Ikemizu S; Misumi S; Ota K; Shinriki S; Kai H; Ando Y
    Ann Clin Biochem; 2008 Sep; 45(Pt 5):489-95. PubMed ID: 18753422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pathogenesis of amyloidosis: a role for anti-proteases?].
    Argilés i Ciscart A; Mourad G
    Nephrologie; 1991; 12(2):51-4. PubMed ID: 1719439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.